Collaboration will harness AI technology to address an aging-related target
NOVATO, US - Media OutReach - August 14 , 2018 - The Buck Institute for Research on Aging, Insilico Medicine, and Juvenescence Ltd announced today that they have formed Napa Therapeutics, Ltd to develop drugs against a novel aging-related target. The Buck...
More...






